The cell culture hydrogel market was valued at $400.0 million in 2023 and is estimated to reach $2.13 billion by 2035, exhibiting a CAGR of 15.0% from 2024 to 2035.
Cell culture hydrogel is a three-dimensional, water-rich polymeric materials designed to mimic the extracellular matrix (ECM) environment for culturing cells in vitro. These hydrogels provide structural support, biochemical cues, and mechanical properties essential for maintaining cellular function, proliferation, and differentiation. They are commonly used in biomedical research, including tissue engineering, regenerative medicine, and drug discovery.
Increase in focus on stem cell therapies and research is a key factors that has fueled the demand for hydrogels, which support stem cell growth and differentiation by mimicking natural cellular environments. In addition, the transition from 2D to 3D cell cultures for drug screening, organoid development, and regenerative medicine has significantly increased the demand for hydrogels. Studies have shown that organoid cultures supported by synthetic hydrogels with tunable mechanical properties enhance reproducibility and mimic organ-like structures more accurately compared to traditional Matrigel scaffolds. Moreover, rising applications in drug discovery and development fuel the growth of the market.
This is attributed to the fact that hydrogels enable the development of 3D models for high-throughput drug screening, enhancing their adoption by pharmaceutical and biotechnology industries. Furthermore, rise in need for advanced in vitro models to study chronic diseases like cancer, cardiovascular conditions, and diabetes is fueling the demand for hydrogels in biomedical research. A 2023 study published by the World Health Organization revealed that approximately 41 million individuals die each year due to chronic diseases. Rise in adoption of organ-on-a-chip technologies, which often incorporate hydrogels to simulate tissue microenvironments, further propels the market.
However, requirement for tailoring hydrogel properties, such as stiffness, porosity, and degradation rate, to suit specific applications demands technical expertise and time, which acts as a barrier for the market growth. Moreover, availability of alternative 3D culture methods such as microcarrier-based cell cultures or scaffold-free methods like spheroids, can pose challenges to the market growth.
On the contrary, innovations in hydrogel formulations, such as smart hydrogels with tunable properties and stimuli-responsive behavior, are expanding their functionality and applications. Rise in research and clinical efforts in tissue engineering and regenerative medicine are boosting the demand for hydrogels, which serve as key biomaterials for creating functional tissue constructs. Such developments are expected to offer lucrative opportunities for the expansion of the global market during the forecast period.
The cell culture hydrogel market is segmented into type of hydrogel, application, end user, and region. By type of hydrogel, the market is segmented into natural hydrogels, synthetic hydrogels, hybrid hydrogels. By application, the market is segmented into cancer and stem cell research, tissue engineering and regenerative medicine, drug discovery and toxicology testing, and others.
By end user, the market is segregated into pharmaceutical and biotechnology companies, CROs, research institution, and others. Region wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and Rest of LAMEA).
On the basis of application, the tissue engineering & regenerative medicine segment garnered the largest share in 2023; however, the cancer & stem cell research segment is expected to grow at the highest CAGR during the forecast period.
By end user, the pharmaceutical and biotechnology companies segment was the major shareholder in 2023; however, the CROs segment is anticipated to exhibit the highest CAGR during the forecast period.
Region wise, North America was the largest shareholder in the global cell culture hydrogel market in 2023; however, Asia-Pacific is anticipated to register the highest CAGR during the forecast period.
Cell culture hydrogel is a three-dimensional, water-rich polymeric materials designed to mimic the extracellular matrix (ECM) environment for culturing cells in vitro. These hydrogels provide structural support, biochemical cues, and mechanical properties essential for maintaining cellular function, proliferation, and differentiation. They are commonly used in biomedical research, including tissue engineering, regenerative medicine, and drug discovery.
Increase in focus on stem cell therapies and research is a key factors that has fueled the demand for hydrogels, which support stem cell growth and differentiation by mimicking natural cellular environments. In addition, the transition from 2D to 3D cell cultures for drug screening, organoid development, and regenerative medicine has significantly increased the demand for hydrogels. Studies have shown that organoid cultures supported by synthetic hydrogels with tunable mechanical properties enhance reproducibility and mimic organ-like structures more accurately compared to traditional Matrigel scaffolds. Moreover, rising applications in drug discovery and development fuel the growth of the market.
This is attributed to the fact that hydrogels enable the development of 3D models for high-throughput drug screening, enhancing their adoption by pharmaceutical and biotechnology industries. Furthermore, rise in need for advanced in vitro models to study chronic diseases like cancer, cardiovascular conditions, and diabetes is fueling the demand for hydrogels in biomedical research. A 2023 study published by the World Health Organization revealed that approximately 41 million individuals die each year due to chronic diseases. Rise in adoption of organ-on-a-chip technologies, which often incorporate hydrogels to simulate tissue microenvironments, further propels the market.
However, requirement for tailoring hydrogel properties, such as stiffness, porosity, and degradation rate, to suit specific applications demands technical expertise and time, which acts as a barrier for the market growth. Moreover, availability of alternative 3D culture methods such as microcarrier-based cell cultures or scaffold-free methods like spheroids, can pose challenges to the market growth.
On the contrary, innovations in hydrogel formulations, such as smart hydrogels with tunable properties and stimuli-responsive behavior, are expanding their functionality and applications. Rise in research and clinical efforts in tissue engineering and regenerative medicine are boosting the demand for hydrogels, which serve as key biomaterials for creating functional tissue constructs. Such developments are expected to offer lucrative opportunities for the expansion of the global market during the forecast period.
The cell culture hydrogel market is segmented into type of hydrogel, application, end user, and region. By type of hydrogel, the market is segmented into natural hydrogels, synthetic hydrogels, hybrid hydrogels. By application, the market is segmented into cancer and stem cell research, tissue engineering and regenerative medicine, drug discovery and toxicology testing, and others.
By end user, the market is segregated into pharmaceutical and biotechnology companies, CROs, research institution, and others. Region wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and Rest of LAMEA).
Key Findings
Depending on type of hydrogel, the synthetic hydrogels segment dominated the share, in terms of share, in 2023, and is expected to register the highest CAGR from 2024 to 2035.On the basis of application, the tissue engineering & regenerative medicine segment garnered the largest share in 2023; however, the cancer & stem cell research segment is expected to grow at the highest CAGR during the forecast period.
By end user, the pharmaceutical and biotechnology companies segment was the major shareholder in 2023; however, the CROs segment is anticipated to exhibit the highest CAGR during the forecast period.
Region wise, North America was the largest shareholder in the global cell culture hydrogel market in 2023; however, Asia-Pacific is anticipated to register the highest CAGR during the forecast period.
Competitive Analysis
The key players that operate in the global cell culture hydrogel market are Corning Incorporated, Merck KGaA, Humabiologics, Inc, Cell Guidance Systems, TheWell Bioscience Inc., CD Bioparticles, BICO, PELOBIOTECH GmbH, UPM, and Cellendes GmbH. These players have adopted expansion, agreement, partnership, and collaboration as their key strategies to strengthen their foothold in the global marketKey Benefits for Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the cell culture hydrogel market analysis from 2023 to 2035 to identify the prevailing cell culture hydrogel market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the cell culture hydrogel market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global cell culture hydrogel market trends, key players, market segments, application areas, and market growth strategies.
Additional benefits you will get with this purchase are:
- Quarterly Update* (with the purchase of an enterprise license)
- 5 additional Company Profiles, pre- or post-purchase, as a free update.
- Free Updated Version (once released) with the purchase of an enterprise user license.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Market share analysis of players by products/segments
- New Product Development/ Product Matrix of Key Players
- Additional company profiles with specific to client's interest
- Expanded list for Company Profiles
- Historic market data
Key Market Segments
By Type of Hydrogel
- Synthetic Hydrogels
- Hybrid Hydrogels
- Natural Hydrogels
By Application
- Cancer and Stem Cell Research
- Tissue Engineering and Regenerative Medicine
- Drug Discovery and Toxicology Testing
- Others
By End User
- Research Institutions
- Others
- Pharmaceutical and Biotechnology Companies
- CROs
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Corning Incorporated
- Merck KGaA
- Humabiologics, Inc
- UPM
- PELOBIOTECH GmbH
- CD Bioparticles
- Cell Guidance Systems
- BICO
- TheWell Bioscience Inc.
- Cellendes GmbH
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: CELL CULTURE HYDROGEL MARKET, BY TYPE OF HYDROGEL
CHAPTER 5: CELL CULTURE HYDROGEL MARKET, BY APPLICATION
CHAPTER 6: CELL CULTURE HYDROGEL MARKET, BY END USER
CHAPTER 7: CELL CULTURE HYDROGEL MARKET, BY REGION
CHAPTER 8: COMPETITIVE LANDSCAPE
CHAPTER 9: COMPANY PROFILES
LIST OF TABLES
LIST OF FIGURES
Companies Mentioned
- Corning Incorporated
- Merck KGaA
- Humabiologics, Inc
- UPM
- PELOBIOTECH GmbH
- CD Bioparticles
- Cell Guidance Systems
- BICO
- TheWell Bioscience Inc.
- Cellendes GmbH
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
